CYSTIC FIBROSIS: Study of Burkholderia strains yields promising leads
Health & Medicine Week, September 15, 2003

	Osteoporosis: Calcitriol improves calcium homeo-stasis in adults with cystic Fibrosis Cystic Fibrosis: Researchers develop new method of determining treatment effects Cystic Fibrosis: Stem cells shown to regenerate damaged lung tissue for first time Cystic Fibrosis: Study of Burkholderia strains yields promising leads Lung transplants pioneered in T.O. As summer heat begins to subside, golf warms up Snap up tickets for trust ball Family Gears Up For A Life-Saving Ride

People with weakened immune systems, including patients with cystic fibrosis, could be better protected in the future from a highly resilient bacteria thanks to work by medical scientists from the University of Leeds.

Their research was presented at the Society for General Microbiology's meeting in Manchester, England.

"British soldiers stationed in Southeast Asia and North Australia, as well as local people, can be exposed to infection by a dangerous bacterium called Burkholderia pseudomallei which causes pneumonia and septicemia. This bacterium is resistant to many antibiotics and, as treatment can take 9 months with frequent relapses, we urgently need to find new ways of combating it," said Dr. Zarina Yousuf from the department of oral biology, University of Leeds.

The scientists have been studying a bacterium from the same family, called B. cepacia, which infects cystic fibrosis patients, in the hope of finding ways of combating it. The work is urgently needed as cystic fibrosis sufferers can easily contract highly infectious strains of the bacteria that cause epidemics. Once infected a patient must be isolated from his or her family and fellow sufferers, drastically affecting quality of life.

"Our research has concentrated on the cell wall which appears to give the bacteria its unusual resistance to antibiotics, especially a fat and sugar component called lipopolysaccharide," said Yousuf. "We hope to identify and target the key genes responsible for modification of lipopolysaccharide, as well as those responsible for a number of internal cell activities. We hope that treatments which work against this bacterium will also be successful against the related, much more dangerous varieties such as B. pseudomallei."

The scientists are also interested in plans to release similar strains of bacteria into the environment where they will be used as biological cleansing or decontamination agents. "We need to fully understand how these bacteria infect people so that we can make sure that only organisms of no danger to humans are released into the environment," said Yousuf. "This could need long-term studies as, for instance, B. pseudomallei can remain hidden in its latent state in infected people for up to 26 years before they become ill."

This article was prepared by Health & Medicine Week editors from staff and other reports.